Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Aug 2026 for Veradermics, Incorporated, €9.4M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
John W. Childs 2013 Revocable Trust: trading record in brief
John W. Childs 2013 Revocable Trust discloses dealings in Veradermics, Inc to SEC (Form 4). Altogether 2 filings, all relating to 12 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 14 August 2026 came the latest disclosure, a transaction for €9.4M in Veradermics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John W. Childs 2013 Revocable Trust
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
100,000 shares@ US$109.05Common StockSEC144:0001628280-26-057194
100,000 shares@ US$109.05Common StockSEC144:0001628280-26-057202
2 of 2 declarations
